Free News Articles, Software

MyDoctorsChat Fully Embraces the AMA’s New Ethical Guidelines for Telemedicine

HOUSTON, Texas -- MHIT Business Services, Inc. - the parent company of MyDoctorsChat - a fully scalable, HIPAA compliant enterprise mobile telemedicine software solution for doctors, patients and healthcare organizations believes that the evolution of telemedicine technology offers improved access to healthcare and provides new, sophisticated opportunities for healthcare providers to address their patients' unique healthcare needs.

On Monday, the AMA adopted guidance for ethical practice in telemedicine, providing specific recommendations to physicians regarding how their fundamental responsibilities might be different when patient interactions occur through telemedicine. MHIT Business Services, Inc. fully embraces the AMA's new guidelines which permit physicians utilizing telehealth and telemedicine technology to exercise discretion in their use of telemedicine.

Dr. Jordan Balencic, Strategic Medical Advisor to MyDoctorsChat, reported that: "We applaud the AMA's encouragement of physicians to become more actively engaged in telemedicine in order to further enhance technology standards, and increase access to patients who want to utilize telemedicine services. Improving safe access to vital healthcare resources has been part of our vision from the beginning."

Will Lowe, CEO and Co-Founder of MHIT Business Services, Inc. stated: "We view ourselves as a systems integration company. Our mobile telemedicine offering from a cost-benefit standpoint makes a lot of sense, especially when addressing the diverse needs of healthcare organizations in their strategic planning and deployment stages. Our cloud-based software enables the implementation of a complete telemedicine solution across a large health network without requiring extensive development costs and time."

Mr. Lowe further stated that "Our aim in licensing the innovative technology behind MyDoctorsChat is to offer healthcare organizations a complete, secure telemedicine solution that strengthens the patient-doctor relationship so that physicians can provide safe, and cost-effective remote care directly to their patients."

MyDoctorsChat provides healthcare organizations with a fully deployed web-based application as well as a complete iOS bundle for the iPhone and iPad along with all Android devices. The iOS and Android Mobile Apps are available in The App Store and Google Play.

"We believe a large opportunity exists in both Mexico and Latin America for telemedicine and were excited about the growing interest from groups in Mexico City and Monterey Mexico," concluded Lowe. "We're excited to begin deploying our technology on a Global scale."

More information: http://mydoctorschat.com/.

MEDIA CONTACT:
Will Lowe
MHIT Business Services Inc
Will@mydoctorschat.com
512-569-6526

This news story was published by the Neotrope® News Network - all rights reserved.

Free News Articles, Software

Gamma Medical Research announces the use of Telemedicine in Clinical Research

MCALLEN, Texas -- Gamma Medical Research, Inc., headed by Dr. Roberto Mangoo-Karim, is excited to announce the licensing of My Doctors Chat to provide Telemedicine in its clinical research programs. Gamma Medical Research, a company dedicated to compassionate medical care and scientific progress, is advancing science and innovation through clinical investigation by conducting pharmaceutical research trials.

My Doctors Chat will serve two functions in our ongoing clinical research programs, states Dr. Mangoo-Karim: One, improving access for those participating in clinical trials and two, improving documentation of any unusual or adverse events patients experience so that it can be recorded as part of the study. My Doctors Chat telemedicine solution offers great potential as an archived video is stored for review at a later date; this makes so much sense for us to be able to review the ongoing effects of clinical research with our participants.

It's a tremendous opportunity for My Doctors Chat to aid in providing more efficient documentation inside the field of clinical research, states Miguel Esparza Jr., CTO and cofounder of MHIT Business Services Inc., the parent company of My Doctors Chat. Licensing our technology bundle to healthcare organizations allows healthcare organizations and physician organizations to offer telemedicine directly to their patients, he stated.

My Doctors Chat (mydoctorschat.com) is a Fully Scalable Enterprise Telemedicine Mobile Software Solution that is a Customizable HIPAA Compliant Mobile Software Application for Doctors, Patients and Healthcare Organizations using IPhones, IPads as well as Android mobile devices.

Roberto Mangoo-Karim, MD, PhD, FACP, FASN is Adjunct Assistant Professor of Medicine at University of Texas Health Science Center San Antonio/RAHC; Nephrology Coordinator Internal Medicine Residency Program at Doctors Hospital at Renaissance/UTHSCSA; Adjunct Assistant Professor of Medicine at Baylor College of Medicine in Houston, Texas; Preceptor of the Physician Assistant Program and Nurse Practitioner Program at the University of Texas-Pan American College of Health and Human Services in Edinburg, Texas; and Adjunct Faculty at the University of Texas Family Practice Residency Program in McAllen, Texas. He is board certified in Internal Medicine and Nephrology.

After receiving his MD from the Instituto Tecnologico y de Estudios Superiores de Monterrey in Monterrey, Mexico, Dr Mangoo-Karim obtained his PhD in Pharmacology at the University of Kansas Medical Center in Kansas City. He pioneered basic research on the pathophysiology of renal cystic disease. American Journal of Physiology, Journal of Clinical Pharmacology and Journal of the American Society of Nephrology.

Dr. Mangoo-Karim is a member of the American Society of Nephrology, Texas Medical Association, and Hidalgo County Medical Society.

More information on Gamma Medical Research, Inc.: http://gammamedicalresearch.com/.

More information on My Doctors Chat from MHIT Business Services, Inc.: http://mydoctorschat.com/.

This news story was published by the Neotrope® News Network - all rights reserved.